Clinical Trials · NCT07338214

Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations

Name: Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Petrelintide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Zealand Pharma
Enrollment: 48
Start date: Dec 2025
Locations: 1 site, Germany
Primary endpoint: To investigate the Pharmacokinetics of a single dose administration of petrelintide administered subcutaneously using 4 different drug product concentrations in participants with overweight or obesity

View Petrelintide compound reference